van Rooij, Sanne J. H. http://orcid.org/0000-0002-0160-7248
Arulpragasam, Amanda R.
McDonald, William M.
Philip, Noah S. http://orcid.org/0000-0002-4889-8775
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (I50 RX002864, P20 GM130452)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01 MH123427, K01MH121653, U01 MH123427)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Brain and Behavior Research Foundation (NARSAD Young Investigator Award)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 28 February 2023
Revised: 20 April 2023
Accepted: 22 April 2023
First Online: 22 May 2023
Change Date: 28 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41386-023-01714-0
Competing interests
: SVR does not report any competing interests. ARA does not report any competing interests. WMM is a member of the American Psychiatric Association (APA) Council on Research representing ECT and Neuromodulation Therapies. He receives funding from NIMH and NIA. Dr. McDonald is compensated as the chair of the DSMB for an NIA sponsored multicenter study. He is on the Board of Skyland Trail and 3Keys. He is a paid consultant for Sage Therapeutics and has been a consultant for Signant Health in the last five years. He has received past funding from the Stanley Foundation, Soterix, Neuronetics, NeoSync and Cervel Neurotherapeutics. He is a deputy editor of the American Journal of Psychiatry and on the editorial boards of the American Journal of Geriatric Psychiatry and Personalized Medicine in Psychiatry. He has endowed chair funded by the JB Fuqua Foundation. He is an employee of Emory University School of Medicine. NSP has received support (through VA contracts) for studies by Neurolief and Wave Neuro in the past 3 years. He serves on the Scientific Advisory Board of Pulvinar Neuro. The views expressed here are the authors’ and do not reflect the position or policies of the NIMH or VA.